A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study

被引:26
|
作者
Kapadia, Shashi N. [1 ,2 ]
Griffin, Judith L. [1 ,3 ]
Waldman, Justine [3 ]
Ziebarth, Nicolas R. [4 ]
Schackman, Bruce R. [2 ]
Behrends, Czarina N. [2 ]
机构
[1] Weill Cornell Med, Dept Med, New York, NY 10065 USA
[2] Weill Cornell Med, Dept Populat Hlth Sci, New York, NY USA
[3] REACH Med, Ithaca, NY USA
[4] Cornell Univ, Dept Policy Anal & Management, Ithaca, NY USA
关键词
buprenorphine; harm reduction; primary care; qualitative; opioid use disorder; TREATMENT RETENTION; TREATMENT OUTCOMES; BUPRENORPHINE; PROFESSIONALS; BARRIERS;
D O I
10.1007/s11606-020-06409-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Stigma is a barrier to the uptake of buprenorphine to treat opioid use disorder. Harm reduction treatment models intend to minimize this stigma by organizing care around non-judgmental interactions with people who use drugs. There are few examples of implementing buprenorphine treatment using a harm reduction approach in a primary care setting in the USA. Methods We conducted a qualitative study by interviewing leadership, staff, and external stakeholders at Respectful, Equitable Access to Compassionate Healthcare (REACH) Medical in Ithaca, NY. REACH is a freestanding medical practice that provides buprenorphine treatment for opioid use disorder since 2018. We conducted semi-structured interviews with 17 participants with the objective of describing REACH's model of care. We selected participants based on their position at REACH or in the community. Interviews were recorded, transcribed, and analyzed for themes using content analysis, guided by the CDC Evaluation Framework. Results REACH provided buprenorphine, primary care, and mental health services in a low-threshold model. We identified three themes related to delivery of buprenorphine treatment. First, an organizational mission to provide equitable and low-stigma healthcare, which was a key to organizational identity. Second, a low-threshold buprenorphine treatment approach that was critical, but caused concern about over-prescribing and presented logistical challenges. Third, creation and retention of a harm reduction-oriented workforce by offering value-based work and by removing administrative barriers providers may face elsewhere to providing buprenorphine treatment. Conclusions A harm reduction primary care model can help reduce stigma for people who use drugs and engage in buprenorphine treatment. Further research is needed to evaluate whether this model leads to improved patient outcomes, can overcome community stakeholder concerns, and is sustainable.
引用
收藏
页码:1898 / 1905
页数:8
相关论文
共 50 条
  • [1] A Harm Reduction Approach to Treating Opioid Use Disorder in an Independent Primary Care Practice: a Qualitative Study
    Shashi N. Kapadia
    Judith L. Griffin
    Justine Waldman
    Nicolas R. Ziebarth
    Bruce R. Schackman
    Czarina N. Behrends
    Journal of General Internal Medicine, 2021, 36 : 1898 - 1905
  • [2] Treating Opioid Use Disorder in General Practice - Diagnosis, Harm Reduction, and Medications
    Bagley, Sarah
    Barnes, Je'Mal
    Blunt, Barbara
    Foreman, Jennifer
    Hadland, Scott
    Mayen, Sandra
    McMahan, Raina
    Punch, L. J.
    Taichman, Darren
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (02):
  • [3] Treating opioid use disorder in primary care
    Perry, Danielle
    Orrantia, Eliseo
    Garrison, Scott
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (02) : 117 - 117
  • [4] Treating Adolescent Opioid Use Disorder in Primary Care
    Hadland, Scott E.
    Burr, William H.
    Zoucha, Kenneth
    Somberg, Chloe A.
    Camenga, Deepa R.
    JAMA PEDIATRICS, 2024, 178 (04) : 414 - 416
  • [5] A novel approach to treating adolescents with opioid use disorder in pediatric primary care
    Levy, Sharon
    Mountain-Ray, Shannon
    Reynolds, Jason
    Mendes, Steven J.
    Bromberg, Jonas
    SUBSTANCE ABUSE, 2018, 39 (02) : 173 - 181
  • [6] Harm Reduction for Opioid Use Disorder
    Agrawal, Alok
    Bhad, Roshan
    Singh, Amit
    Rao, Ravindra
    INDIAN JOURNAL OF PSYCHIATRY, 2019, 61 (09) : S423 - S423
  • [7] Barriers and Facilitators to Harm Reduction for Opioid Use Disorder: A Qualitative Study of People With Lived Experience
    Westafer, Lauren M.
    Beck, Samantha A.
    Simon, Caty
    Potee, Benjamin
    Soares, William E.
    Schoenfeld, Elizabeth M.
    ANNALS OF EMERGENCY MEDICINE, 2024, 83 (04) : 340 - 350
  • [8] Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study
    Incze, Michael A.
    Chen, David
    Galyean, Patrick
    Kimball, Elisabeth R.
    Stolebarger, Laura
    Zickmund, Susan
    Gordon, Adam J.
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (04) : 401 - 406
  • [9] Harm Reduction Strategies for Opioid Use Disorder
    Knio, Laila
    Capurso, Noah
    CURRENT ADDICTION REPORTS, 2025, 12 (01)
  • [10] A rational approach to opioid use disorder in primary care
    Tobin, Daniel G.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2017, 84 (05) : 385 - 387